These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 512846)

  • 1. A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism.
    Colburn WA
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):407-15. PubMed ID: 512846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of intestinal first-pass drug metabolism.
    Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A
    Curr Drug Metab; 2007 Oct; 8(7):676-84. PubMed ID: 17979655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.
    Pang KS; Gillette JR
    J Pharm Sci; 1978 May; 67(5):703-4. PubMed ID: 641815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal first-pass metabolism: bridging the gap between in vitro and in vivo.
    Galetin A
    Curr Drug Metab; 2007 Oct; 8(7):643-4. PubMed ID: 17979662
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential organ first-pass effects: simple methods for constructing compartmental pharmacokinetic models from physiological models of drug disposition by several organs.
    Gillette JR
    J Pharm Sci; 1982 Jun; 71(6):673-7. PubMed ID: 7097532
    [No Abstract]   [Full Text] [Related]  

  • 7. The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans.
    Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
    J Pharm Sci; 2009 Nov; 98(11):4343-53. PubMed ID: 19230019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [First-pass effect as a therapeutic problem].
    Danek A
    Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.
    Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
    Biol Pharm Bull; 2010; 33(1):111-6. PubMed ID: 20045946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presystemic extraction: mechanisms and consequences.
    Greenblatt DJ
    J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.
    Klippert PJ; Littel RJ; Noordhoek J
    J Pharmacol Exp Ther; 1983 Apr; 225(1):153-7. PubMed ID: 6834267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Route of administration and drug disposition.
    Gibaldi M; Perrier D
    Drug Metab Rev; 1974; 3(2):185-99. PubMed ID: 4607867
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development.
    Karlsson FH; Bouchene S; Hilgendorf C; Dolgos H; Peters SA
    Drug Metab Dispos; 2013 Dec; 41(12):2033-46. PubMed ID: 23918667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective.
    Fisher MB; Labissiere G
    Curr Drug Metab; 2007 Oct; 8(7):694-9. PubMed ID: 17979657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of drugs and other xenobiotics in the gut lumen and wall.
    Ilett KF; Tee LB; Reeves PT; Minchin RF
    Pharmacol Ther; 1990; 46(1):67-93. PubMed ID: 2181492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):289-308. PubMed ID: 3783448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.